" />
English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 26 February 2014, 10:40 HKT/SGT
Share:
    

Source: Research and Markets
Neuroprotection-An In-Depth Report Covering Key Topics Including Drugs, Markets and Companies

DUBLIN, IRELAND, Feb 26, 2014 - (ACN Newswire) - Research and Markets (http://www.researchandmarkets.com/research/hhg7xg/neuroprotection) has announced the addition of a new report "Neuroprotection - Drugs, Markets and Companies" to their offering.

This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many of the underlying mechanisms of damage to neural tissues are similar in all these conditions and several products are used in more than one disorder. Over 500 products have been investigated for neuroprotective effects including those from the categories of free radical scavengers, anti-excitotoxic agents, apoptosis (programmed cell death) inhibitors, anti-inflammatory agents, neurotrophic factors, metal ion chelators, ion channel modulators and gene therapy. Some of the agents are old established pharmaceuticals whereas others are new biotechnology products.

Pathomechanisms of diseases are described with steps at which neuroprotective therapies are directed. Diseases covered include cerebrovascular disorders, traumatic brain injury, spinal cord injury, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy and ischemic optic neuropathy as well as retinal degeneration. Although anesthetics such as propofol are neuroprotective as well, neuroprotection during surgery and anesthesia is discussed with the aim of preventing and treating complications that result in CNS damage.

The report contains profiles of 139 companies that have a neuroprotective product or products along with 121 collaborations. Some of the products in development at academic institutions that do not have a commercial sponsor are also included. Although an up-to-date search of the literature was performed and selected 1,000 references are included. Clinical trials of various neuroprotective agents are described and failures of trials are analyzed with suggestions for improving the selection of drugs and design of trials. The report is supplemented with 70 tables and 13 figures.

Market analysis of currently used products that have a neuroprotective effect are analyzed for the year 2013. Some of these products are approved for other indications but are known to have a neuroprotective effect. With the approval of new products and takeover of markets for obsolete symptomatic therapies, the neuroprotection market value will rise by the year 2018 when it will constitute a major and important component of the CNS market. Forecasts are made until 2023. By that time neuroprotection will be an established part of the neurological practice and measures will be available to achieve this effectively.

Key Topics Covered:

Part I: Drugs & Markets

Executive Summary

1. Introduction
2. Neuroprotective Agents
3. Neuroprotection in Cerebrovascular Disease
4. Neuroprotection in Traumatic Brain Injury
5. Neuroprotection in Spinal Cord Injury
6. Neuroprotection in Neurodegenerative Disorders
7. Neuroprotection in Parkinson Disease
8. Neuroprotection in Alzheimer Disease
9. Neuroprotection in Huntington Disease
10. Neuroprotection in Amyotrophic Lateral Sclerosis
11. Neuroprotection in Miscellaneous Neurological Disorders
12. Neuroprotection of the Optic nerve and the Retina
13. Neuroprotection during Anesthesia and Surgery
14. Markets for Neuroprotective Therapies
15. References

Part II

16. Companies Developing Neuroprotective Therapies

For more information visit http://www.researchandmarkets.com/research/hhg7xg/neuroprotection

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology

Topic: Research / Industry Report
Source: Research and Markets


https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Research and Markets Related News
Aug 19, 2014 10:55 HKT/SGT
Global Rare Earths (Magnets, Batteries, Catalysts) Industry 2014 - Forecasts to 2017
Aug 19, 2014 10:35 HKT/SGT
Global Healthcare Analytics Market Report 2014 - Forecast to 2019
Aug 19, 2014 10:15 HKT/SGT
Global Industrial Rubber Products (Mechanical Rubber Goods, Rubber Hose and Belting) Market-Strategic Business Report: Forecasts to 2020
Aug 18, 2014 09:55 HKT/SGT
Global e-Learning Report 2014-2020 - Strategic Business Report
Aug 14, 2014 11:20 HKT/SGT
Global IR Detector (MCT, InGaAs, Pyroelectric, Thermopyle, Microbolometer) Market - Forecast to 2020
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575